Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells

Genes Chromosomes and Cancer

Volumn 53, Issue 5, 2014, Pages 422-431

  Xie, Qi ^a   Bai, Qian ^a   Zou, Ling Yun ^a   Zhang, Qian Yong ^a   Zhou, Yong ^a   Chang, Hui ^a   Yi, Long ^a   Zhu, Jun Dong ^a   Mi, Man Tian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GENISTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SERINE PROTEINASE INHIBITOR; STRATIFIN;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; COLON POLYPOSIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MODEL; MULTIPLE CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ATAXIA TELANGIECTASIA;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENES, TUMOR SUPPRESSOR; GENISTEIN; GENOME, HUMAN; HUMANS; MODELS, MOLECULAR;

EID: 84895922467     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22154     Document Type: Article

References (43)

1. Adjakly M, Bosviel R, Rabiau N, Boiteux J-P, Bignon Y-J, Guy L, Bernard-Gallon D. 2011. DNA methylation and soy phytoestrogens: Quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics 3:795-803.
2. Banerjee S, Li Y, Wang Z, Sarkar FH. 2008. Multi-targeted therapy of cancer by genistein. Cancer Lett 269:226-242.
3. Baylin SB, Ohm JE. 2006. Epigenetic gene silencing in cancer-A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107-116.
4. Billington CJ, Jr., Schmidt B, Zhang L, Hodges JS, Georgieff MK, Schotta G, Gopalakrishnan R, Petryk A. 2013. Maternal diet supplementation with methyl donors and increased parity affect the incidence of craniofacial defects in the offspring of twisted gastrulation mutant mice. J Nutr 143:332-339.
5. Bosviel R, Dumollard E, Dechelotte P, Bignon YJ, Bernard-Gallon D. 2012. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS 16:235-244.
6. Christman JK. 2002. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy. Oncogene 21:5483-5495.
7. Dampier K, Hudson EA, Howells LM, Manson MM, Walker RA, Gescher A. 2001. Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer 85:618-624.
8. Dworkin AM, Huang TH, Toland AE. 2009. Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol 19:165-171.
9. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG. 2000. Analysis of adenomatous polyposis Coli promoter hypermethylation in human cancer. Cancer Res 60:4366-4371.
10. Fang M, Chen D, Yang CS. 2007. Dietary polyphenols may affect DNA methylation. J Nutr 137:223S-228S.
11. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. 2003. Tea Polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63:7563-7570.
12. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. 2005. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11:7033-7041.
13. Feil R, Fraga MF. 2011. Epigenetics and the environment: Emerging patterns and implications. Nat Rev Genet 13:97-109.
14. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S. 2000. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97:6049-6054.
15. Garcia JM, Silva J, Pena C, Garcia V, Rodriguez R, Cruz MA, Cantos B, Provencio M, Espana P, Bonilla F. 2004. Promoter methylation of the PTEN gene is a common molecular change in breast cancer. Genes Chromosomes Cancer 41:117-124.
16. Herman JG, Baylin SB. 2003. Gene silencing in cancer in association with promoter hypermethylation. New England J Med 349:2042-2054.
17. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826.
18. Hui C, Yujie F, Lijia Y, Long Y, Hongxia X, Yong Z, Jundong Z, Qianyong Z, Mantian M. 2012. MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3, 6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis. Breast Cancer Res 14:R80.
19. Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z, Mantian M. 2013. Flavonoids, flavonoid subclasses and breast cancer risk:A meta-analysis of epidemiologic studies. PLoS One 8:e54318.
20. Issa JP. 2008. Cancer prevention: Epigenetics steps up to the plate. Cancer Prev Res (Phila) 1:219-222.
21. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin 61:69-90.
22. Jirtle RL, Skinner MK. 2007. Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253-262.
23. Jones PA. 2002. DNA methylation and cancer. Oncogene 21:5358-5360.
24. Jovanovic J, Ronneberg JA, Tost J, Kristensen V. 2010. The epigenetics of breast cancer. Mol Oncol 4:242-254.
25. King-Batoon A, Leszczynska JM, Klein CB. 2008. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 49:36-45.
26. Li Y, Tollefsbol TO. 2010. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 17:2141-2151.
27. Li Y, Liu L, Andrews LG, Tollefsbol TO. 2009. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int J Cancer 125:286-296.
28. Link A, Balaguer F, Goel A. 2010. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem Pharmacol 80:1771-1792.
29. Lo PK, Sukumar S. 2008. Epigenomics and breast cancer. Pharmacogenomics 9:1879-1902.
30. Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B, Fabianowska-Majewska K. 2013. Folic acid enforces DNA methylation-mediated transcriptional silencing of |PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. Biochem Biophys Res Commun 430:623-628.
31. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, Tanaka Y, Dahiya AV, Dahiya R. 2010. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-cell translocation gene 3 in prostate cancer. Cancer 116:66-76.
32. Medina-Franco JL, Caulfield T. 2011. Advances in the computational development of DNA methyltransferase inhibitors. Drug Discov Today 16:418-425.
33. Meeran SM, Patel SN, Tollefsbol TO. 2010. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 5:e11457.
34. Merchant K, Kumi-Diaka J, Rathinavelu A, Esiobu N, Zoeller R, Hartmann J, Johnson M. 2011. Molecular basis of the anti-cancer effects of genistein isoflavone in LNCaP prostate cancer cells. Functional Foods in Health Dis 1:91-105.
35. Ouyang G, Yao L, Ruan K, Song G, Mao Y, Bao S. 2009. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways. Cell Biol Int 33:1237-1244.
36. Polyak K. 2007. Breast cancer: Origins and evolution. J Clin Invest 117:3155-3163.
37. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR. 2003. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33:61-65.
38. Siedlecki P, Boy RG, Comagic S, Schirrmacher R, Wiessler M, Zielenkiewicz P, Suhai S, Lyko F. 2003. Establishment and functional validation of a structural homology model for human DNA methyltransferase 1. Biochem Biophys Res Commun 306:558-563.
39. Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, Kurie JM, Mao L, Khuri FR. 2002. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 8:1178-1184.
40. Vo QN, Kim WJ, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD. 2004. The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene 23:9432-9437.
41. Waterland RA, Jirtle RL. 2003. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23:5293-5300.
42. Wu Y, Alvarez M, Slamon DJ, Koeffler P, Vadgama JV. 2010. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. BMC Cancer 10:32.
43. Xie Q, Chen ML, Qin Y, Zhang QY, Xu HX, Zhou Y, Mi MT, Zhu JD. 2013. Isoflavone consumption and risk of breast cancer: A dose-response meta-analysis of observational studies. Asia Pac J Clin Nutr 22:118-127.